FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to the development of the combined preparation based on sodium metamizole and tempidon eliciting analgetic, antipyretic and spasmolytic activity. Preparation is made as an envelope-covered tablet. Tablet core comprises active substances sodium metamizole and tempidon and accessory substances - maize starch, microcrystalline cellulose, polyvinylpyrrolidone, sodium starch, glycolate, talk and magnesium stearate. Envelope comprises Opadory Green, titanium dioxide, talk, polyethylene glycol-6000, dye blue, quinoline yellow. The combined preparation shows low toxicity, it doesn't induce disturbances of biochemical and hematological indices of blood owing to qualitative and quantitative ratio of components.
EFFECT: improved and valuable medicinal properties of preparation.
2 dwg, 8 tbl
Title | Year | Author | Number |
---|---|---|---|
"PANZYM FORTE" ENZYMATIC PREPARATION | 2002 |
|
RU2225724C1 |
SPASMOLYTIC TABLETS BRALANGIN | 2001 |
|
RU2203041C1 |
ANTIFUNGAL AGENT "BRAMISIL" | 2002 |
|
RU2214237C1 |
ANTIFUNGAL AGENT "BRIZORAL" | 2002 |
|
RU2205008C1 |
ANTIHISTAMINE PREPARATION "SUBRESTIN" | 2002 |
|
RU2203663C1 |
FERESTAL POLYENZYMATIC PREPARATION | 2001 |
|
RU2201763C1 |
PHARMACEUTICAL COMPOSITION SHOWING ANALGETIC, ANTI-INFLAMMATORY, ANTIPYRETIC AND SPASMOLYTIC EFFECT | 2001 |
|
RU2183116C1 |
PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
MEDICINAL AGENT BRILID WITH ANTIBIOTIC EFFECT | 2001 |
|
RU2207120C1 |
COMPOSITE PHARMACEUTICAL COMPOSITION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247561C1 |
Authors
Dates
2004-09-10—Published
2003-03-04—Filed